Product Usage
This product is intended for research purposes only. All product information available on this website is for educational purposes only. This product is not intended for consumption or bodily introduction of any kind. It should only be handled by licensed and qualified professionals. It is not a drug, food, or cosmetic, and must not be misbranded, misused, or mislabeled as such.
CJC-1295 DAC
PURITY ≥99%/LOT LL-0824/HPLC VERIFIED
Select Your Dosage
CJC-1295 DAC — GHRH Analog + Drug Affinity Complex. 5 mg.
FDA Disclaimer: The statements made within this website have not been evaluated by the US Food and Drug Administration. The statements and the products of this company are not intended to diagnose, treat, cure or prevent any disease. All products are for laboratory developmental research USE ONLY. Not intended for consumption of any kind.
03 / Research Context
Research context
CJC-1295 DAC is a GHRH analog with a maleimidopropionic acid linker that covalently binds serum albumin. This conjugation extends its half-life, providing sustained GHRHR stimulation and elevated IGF-1 transcription.
Key research areas
- Extended 6-8 day half-life via albumin binding
- Sustained baseline GH and IGF-1 elevation
- Less frequent dosing vs. non-DAC version
- Clinically demonstrated 2-10x GH increase
- GHRHR receptor agonist
- Continuous growth hormone release pattern
Handling & reconstitution
Supplied as a lyophilized powder. Bacteriostatic water is the recommended solvent for reconstitution in research applications. Store unreconstituted product at -20°C; reconstituted solutions should be stored at 2-8°C and used within 14–30 days.
Research use only. Not for human consumption.
Product specifications
| Type | GHRH Analog + Drug Affinity Complex |
| Composition | 5 mg |
| Purity | 99%+ |
| Appearance | Lyophilized Powder |
| Storage | 2-8°C |
